Table 3.
Category | Subcategory | Unadjusted HR (95% CI) | Adjusted HR (95% CI) |
---|---|---|---|
Sex | Male | 1.23 (1.0–1.4) | 1.15 (1.0–1.3) |
Female | 1 | 1 | |
Kaposi sarcoma | Yes | 1.26 (1.0–1.5) | 1.01 (0.7–1.2) |
No | 1 | 1 | |
WHO stage | 1 | 1 | 1 |
2 | 0.97 (0.7–1.3) | 1.23 (0.9–1.6) | |
3 | 1.45 (1.1–1.8) | 1.30 (1.0–1.6) | |
4 | 2.10 (1.6–2.6) | 1.91 (1.4–2.5) | |
BMI (kg/m2) | <16 | 1.91 (1.5–2.3) | 1.51 (1.2–1.8) |
16–18.5 | 1.42 (1.1–1.7) | 1.51 (1.2–1.8) | |
≥18.5 | 1 | 1 | |
ART status at presentation | Yes | 13.96 (11.7–16.5) | 13.71 (11.4–16.4) |
No | 1 | 1 | |
ART regimen | First line | 1 | NA |
Second line | 0.74 (0.4–1.2) | ||
Year of admission | 2009 | 1 | 1 |
2010 | 1.14 (0.9–1.3) | 1.29 (1.0–1.5) | |
2011 | 1.43 (1.2–1.6) | 1.61 (1.3–1.9) |
HR, hazard ratio; CI, confidence interval; WHO, World Health Organization; BMI, body mass index; ART, antiretroviral therapy.
Hazard ratios in bold font are statistically significant (P value less than 0.05).